Background: Surfactant protein-D (SP-D) is a lung-resident protein that has emerged as a potential biomarker for COVID-19. Previous investigations on acute respiratory distress syndrome patients demonstrated a significant increment of SP-D serum levels in pathological conditions. Since SP-D is not physiologically permeable to alveoli-capillary membrane and poorly expressed by other tissues, this enhancement is likely due to an impairment of the pulmonary barrier caused by prolonged inflammation. Methods: A retrospective study on a relatively large cohort of patients of Hospital Pio XI of Desio was conducted to assess differences of the hematic SP-D concentrations among COVID-19 patients and healthy donors and if SP-D levels resulted a risk factor for disease severity and mortality. Results: The first analysis, using an ANOVA-model, showed a significant difference in the mean of log SP-D levels between COVID-19 patients and healthy donors. Significant variations were also found between dead vs survived patients. Results confirm that SP-D concentrations were significantly higher for both hospitalized COVID-19 and dead patients, with threshold values of 150 and 250 ng/mL, respectively. Further analysis conducted with Logistic Mixed models, highlighted that higher SP-D levels at admission and increasing differences among follow-up and admission values resulted the strongest significant risk factors of mortality (model predictive accuracy, AUC = 0.844). Conclusions: The results indicate that SP-D can be a predictive marker of COVID-19 disease and its outcome. Considering its prognostic value in terms of mortality, the early detection of SP-D levels and its follow-up in hospitalized patients should be considered to direct the therapeutic intervention.

Salvioni, L., Testa, F., Sulejmani, A., Pepe, F., Lovaglio, P., Berta, P., et al. (2022). Surfactant protein D (SP-D) as a biomarker of SARS-CoV-2 infection. CLINICA CHIMICA ACTA, 537(1 December 2022), 140-145 [10.1016/j.cca.2022.10.013].

Surfactant protein D (SP-D) as a biomarker of SARS-CoV-2 infection

Salvioni, Lucia;Testa, Filippo;Sulejmani, Adela;Pepe, Francesca;Lovaglio, Pietro Giorgio;Berta, Paolo;Dominici, Roberto;Leoni, Valerio;Prosperi, Davide;Vittadini, Giorgio;Colombo, Miriam
;
Fiandra, Luisa
2022

Abstract

Background: Surfactant protein-D (SP-D) is a lung-resident protein that has emerged as a potential biomarker for COVID-19. Previous investigations on acute respiratory distress syndrome patients demonstrated a significant increment of SP-D serum levels in pathological conditions. Since SP-D is not physiologically permeable to alveoli-capillary membrane and poorly expressed by other tissues, this enhancement is likely due to an impairment of the pulmonary barrier caused by prolonged inflammation. Methods: A retrospective study on a relatively large cohort of patients of Hospital Pio XI of Desio was conducted to assess differences of the hematic SP-D concentrations among COVID-19 patients and healthy donors and if SP-D levels resulted a risk factor for disease severity and mortality. Results: The first analysis, using an ANOVA-model, showed a significant difference in the mean of log SP-D levels between COVID-19 patients and healthy donors. Significant variations were also found between dead vs survived patients. Results confirm that SP-D concentrations were significantly higher for both hospitalized COVID-19 and dead patients, with threshold values of 150 and 250 ng/mL, respectively. Further analysis conducted with Logistic Mixed models, highlighted that higher SP-D levels at admission and increasing differences among follow-up and admission values resulted the strongest significant risk factors of mortality (model predictive accuracy, AUC = 0.844). Conclusions: The results indicate that SP-D can be a predictive marker of COVID-19 disease and its outcome. Considering its prognostic value in terms of mortality, the early detection of SP-D levels and its follow-up in hospitalized patients should be considered to direct the therapeutic intervention.
Articolo in rivista - Articolo scientifico
COVID-19; Mortality; SARS-CoV-2 infection; Surfactant protein-D (SP-D);
English
29-ott-2022
2022
537
1 December 2022
140
145
reserved
Salvioni, L., Testa, F., Sulejmani, A., Pepe, F., Lovaglio, P., Berta, P., et al. (2022). Surfactant protein D (SP-D) as a biomarker of SARS-CoV-2 infection. CLINICA CHIMICA ACTA, 537(1 December 2022), 140-145 [10.1016/j.cca.2022.10.013].
File in questo prodotto:
File Dimensione Formato  
Salvioni-2022-Cinica Chimica Acta-VoR.pdf

Solo gestori archivio

Descrizione: Research Article
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 631.52 kB
Formato Adobe PDF
631.52 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/396742
Citazioni
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 7
Social impact